79T-31401-35711
3 vaccinations
7 coded responses
36 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 604 / IL
- Registered
- 2021-03-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-21
Registered in v-safe
-
2021-03-21
Dose 1 — Pfizer-BioNTech
-
2021-03-21
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Nausea, DiarrheaAdult check-in
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-04-04
- 2021-04-11
-
2021-04-18
Dose 2 — Pfizer-BioNTech
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-04-21
-
2021-04-27
Survey response — day 7, dose 2MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Fever · Headache, Fatigue or tirednessFree text: Sore throat, congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-02
Survey response — day 14, dose 2MedDRA: Bronchitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: BronchitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-02
Report sent to call center — day 14, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-09
- 2021-05-16
- 2021-05-25
- 2021-05-30
-
2021-07-19
Survey response — 3 months, dose 2MedDRA: Abdominal distension, Arthralgia, Dysmenorrhoea, Heavy menstrual bleeding — Feeling: GoodFree text: Achy joints, mainly knees and ankles. Heavy monthly cycles with severe cramps and blaoting.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-17
Survey response — 6 months, dose 2MedDRA: Menstruation irregular — Feeling: FairFree text: Change to menstrual cycle and severityMedDRA releases: 2024-11 · check-in free text available
-
2021-10-24
Dose 3 — Pfizer-BioNTech
-
2021-10-24
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
-
2021-10-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-10-26
- 2021-10-27
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-29
- 2021-10-31
- 2021-11-07
- 2021-11-14
-
2021-11-21
Survey response — day 28, dose 3MedDRA: Menstruation irregular — Feeling: GoodFree text: Severe change in menstrual cycle since getting all 3 vaccines.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-28
Survey response — day 35, dose 3MedDRA: Heavy menstrual bleeding, Menstruation irregular — Feeling: FairFree text: Continued issues with menstrual cycle. Went from 28 to 31 day cycles to less than 25 days. Cycles are heavier than they were pre vaccines and last 7 plus days instead of 4 to 5.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-05
Survey response — day 42, dose 3MedDRA: Ageusia, Exposure to SARS-CoV-2, Malaise, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Covid symptoms after direct exposure. Experiencing loss of taste still after other symptoms resolved. Tested negative 2 days after my children tested positive and did not retestMedDRA releases: 2024-11 · check-in free text available
-
2021-12-05
Report sent to call center — day 42, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-06
Call successfulDoes not wish to fill out VAERS report
-
2021-12-13
Call successfulDoes not wish to fill out VAERS report
- 2022-01-23
- 2022-04-24
- 2022-10-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-21 | Pfizer-BioNTech | |
| 2 | 2021-04-18 | Pfizer-BioNTech | |
| 3 | 2021-10-24 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 8 — day 7, dose 2
Systemic reaction (other): Sore throat, congestion
Release 8 — day 14, dose 2
Symptoms: Bronchitis
Release 9 — 3 months, dose 2
Symptoms: Achy joints, mainly knees and ankles. Heavy monthly cycles with severe cramps and blaoting.
Release 10 — 6 months, dose 2
Symptoms: Change to menstrual cycle and severity
Release 10 — day 28, dose 3
Symptoms: Severe change in menstrual cycle since getting all 3 vaccines.
Release 10 — day 35, dose 3
Symptoms: Continued issues with menstrual cycle. Went from 28 to 31 day cycles to less than 25 days. Cycles are heavier than they were pre vaccines and last 7 plus days instead of 4 to 5.
Release 10 — day 42, dose 3
Symptoms: Covid symptoms after direct exposure. Experiencing loss of taste still after other symptoms resolved. Tested negative 2 days after my children tested positive and did not retest
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal distension | · | · | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Bronchitis | ✓ | ✓ | ✓ |
| SD | Dysmenorrhoea | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release